Cargando…

Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation

BACKGROUND: Cinnamic acid (CA) has been shown to have many beneficial effects including regulating lipid metabolism and reducing obesity. However, its effect on nonalcoholic fatty liver disease (NAFDL) has not been investigated in detail. Thus, we performed this study in order to explore CA's e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, You, Wang, Minghui, Yang, Tao, Qin, Lingling, Hu, Yaomu, Zhao, Dan, Wu, Lili, Liu, Tonghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433026/ https://www.ncbi.nlm.nih.gov/pubmed/34512784 http://dx.doi.org/10.1155/2021/9561613

Ejemplares similares

Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease
por: Ran, Li-Sha, et al.
Publicado: (2022)

A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid utilization
por: Liu, Sihao, et al.
Publicado: (2013)

Clitorin ameliorates western diet-induced hepatic steatosis by regulating lipogenesis and fatty acid oxidation in vivo and in vitro
por: Cominguez, Divina C., et al.
Publicado: (2022)

Mechanisms for Improving Hepatic Glucolipid Metabolism by Cinnamic Acid and Cinnamic Aldehyde: An Insight Provided by Multi-Omics
por: Wu, You, et al.
Publicado: (2022)

Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats
por: Zhong, Yujie, et al.
Publicado: (2022)

Ruscogenin Ameliorates Experimental Nonalcoholic Steatohepatitis via Suppressing Lipogenesis and Inflammatory Pathway
por: Lu, Hung-Jen, et al.
Publicado: (2014)

Amycenone reduces excess body weight and attenuates hyperlipidaemia by inhibiting lipogenesis and promoting lipolysis and fatty acid β-oxidation in KK-A(y) obese diabetic mice
por: Kudo, Maya, et al.
Publicado: (2022)

Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress
por: Ji, Yun, et al.
Publicado: (2019)

Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance
por: Roumans, Kay H. M., et al.
Publicado: (2020)

Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis
por: Liu, Yan, et al.
Publicado: (2018)

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
por: Green, Charlotte J, et al.
Publicado: (2020)

Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice
por: Takahara, Ikuko, et al.
Publicado: (2017)

Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice
por: Kong, Qin, et al.
Publicado: (2016)

Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers
por: Rosqvist, Fredrik, et al.
Publicado: (2019)

Cinnamic acid regulates the intestinal microbiome and short-chain fatty acids to treat slow transit constipation
por: Jiang, Jin-Guang, et al.
Publicado: (2023)

Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice
por: Takahara, Ikuko, et al.
Publicado: (2020)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Granulocytic MDSC with Deficient CCR5 Alleviates Lipogenesis and Inflammation in Nonalcoholic Fatty Liver Disease
por: Liao, Tzu-Chieh, et al.
Publicado: (2022)

Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver
por: Fu, Xiaorong, et al.
Publicado: (2023)

Long noncoding RNA lnc_217 regulates hepatic lipid metabolism by modulating lipogenesis and fatty acid oxidation
por: Yuan, Xiaoqing, et al.
Publicado: (2023)

Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice
por: Cruz, Maysa M., et al.
Publicado: (2020)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

Zishen Pill alleviates diabetes in Db/db mice via activation of PI3K/AKT pathway in the liver
por: Wu, You, et al.
Publicado: (2022)

Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms
por: Mak, Kit-Kay, et al.
Publicado: (2023)

B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36
por: Zhang, Hao, et al.
Publicado: (2022)

S-Allyl cysteine improves nonalcoholic fatty liver disease in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats via regulation of hepatic lipogenesis and glucose metabolism
por: Takemura, Shigekazu, et al.
Publicado: (2013)

Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
por: Lu, Wenxia, et al.
Publicado: (2016)

Multifunctional Cinnamic Acid Derivatives
por: Peperidou, Aikaterini, et al.
Publicado: (2017)

Ilexsaponin A(1) Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism in Mice
por: Zhao, Wen-wen, et al.
Publicado: (2021)

Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling
por: Zhong, Jing, et al.
Publicado: (2023)

Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients
por: Li, Fuxi, et al.
Publicado: (2021)

Hepatic Innervations and Nonalcoholic Fatty Liver Disease
por: Adori, Monika, et al.
Publicado: (2023)

Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model
por: Guzman, Stephania, et al.
Publicado: (2022)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake
por: Cedó, Lídia, et al.
Publicado: (2017)

Multitarget Molecular Hybrids of Cinnamic Acids
por: Peperidou, Aikaterini, et al.
Publicado: (2014)

Cinnamic Acid Derivatives and Their Biological Efficacy
por: Ruwizhi, Ngonidzashe, et al.
Publicado: (2020)

Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study
por: Zhang, Juanwen, et al.
Publicado: (2014)

Short-Term Growth Hormone Administration Mediates Hepatic Fatty Acid Uptake and De Novo Lipogenesis Gene Expression in Obese Rats
por: Likitnukul, Sutharinee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2tgvpr5mnf0cfmo11igi44mpoo